YOLFTbeta
Nosa Med AB

Nosa Med AB

NOSA · ST · Healthcare / Medical Devices

0.4795SEK+0.01 (+2.57%)

Price History

Full chart

Market Stats

Previous Close0.4675
Open0.467
Day Range0.443 – 0.4795
52-Week Range0.419 – 0.735
Volume41.52K
Market Cap122.02M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta-0.71
50-Day Avg0.4761
200-Day Avg0.5364

About

Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, Europe, North America, Oceania, and internationally. It offers NOSA smell training, a smell training medical device to improve the sense of smell for individuals with parosmia and hyposmia; NOSA odor control, which reduces bad odor; NOSA microbial control that reduces the exposure of viruses and bacteria by inhalation through the nose; NOSA Nozoil original, a moisturizing nasal spray for people suffering from dry nasal mucosa; and NOSA Cerevia, a nasal drug delivery platform for controlled administration of drugs. The company was incorporated in 2014 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOAdrian Liljefors
  • Employees7
  • HeadquartersSurbrunnsgatan 42, Stockholm, Sweden, 113 48, Sweden
  • Websitehttps://nosaplugs.com

Leadership

  • Adrian LiljeforsChief Executive Officer · b. 1989
  • Karin NilssonChief Financial Officer · b. 1973

Financials

Income Statement

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-248.00K5.25M1.94M1.37M5.85M6.85M10.39M16.10M23.91M
Growth (%)--+2018.95%-63.16%-29.39%+328.24%+17.01%+51.72%+54.88%+48.52%
Cost of Revenue100.00K32.79M52.67M76.40M104.96M12.30M2.08M3.47M4.90M31.94M
Gross Profit-100.00K-32.55M-47.42M-74.46M-103.59M-6.45M-13.64M6.92M11.20M-8.03M
Gross Margin--13123.39%-902.32%-3846.23%-7578.27%-110.13%-199.20%66.59%69.57%-33.60%
Operating Expense24.08M000245.00K0137.00K53.46M21.52M0
Operating Income-24.18M-32.55M-47.42M-74.46M-103.84M-6.45M-13.78M-46.54M-10.32M-8.03M
Operating Margin--13123.39%-902.32%-3846.23%-7596.20%-110.13%-201.20%-447.81%-64.11%-33.60%
EBITDA-24.08M-29.62M-37.81M-69.63M-204.69M-38.60M-7.59M-44.98M-8.45M-4.12M
EBITDA Margin--11943.55%-719.56%-3596.38%-14973.30%-659.43%-110.74%-432.76%-52.51%-17.23%
Net Income-18.30M-24.89M-42.02M-73.76M-229.12M-58.56M-17.82M-46.55M-10.16M-8.04M
Net Income Margin--10037.90%-799.52%-3810.07%-16760.42%-1000.43%-260.18%-447.94%-63.10%-33.63%
R&D-------137.00K--
R&D as % of Total Revenue-------1.32%--
Interest Expense-2.00K2.00K378.00K222.00K-303.00K92.00K81.00K33.00K
Interest Expense % of Total Revenue-0.81%0.04%19.52%16.24%-4.42%0.89%0.50%0.14%

Balance Sheet

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets171.66M199.72M214.60M203.64M116.25M40.09M21.67M33.08M20.70M64.71M
Total Liabilities3.60M7.49M14.21M15.79M14.61M980.00K3.33M6.33M4.14M23.65M
Total Equity168.06M192.22M200.39M187.85M101.64M39.10M6.70M26.75M16.56M41.06M
Cash41.50M42.51M41.89M26.70M87.81M10.40M12.61M1.19M4.31M17.30M
Total Debt---6.80M3.28M9.04M1.72M1.88M1.01M716.00K
Net Debt-41.50M-42.51M-41.89M-19.91M-84.53M-1.36M-10.89M692.00K-3.31M-16.58M

Cash Flow

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-23.48M-27.78M-35.09M-52.72M-69.96M-6.21M-6.93M-17.50M-10.03M-6.39M
Investing Cash Flow-5.79M-18.18M-15.52M-20.41M-8.21M-52.20M-61.00K14.55M-4.71M-12.40M
Financing Cash Flow35.76M46.97M49.99M58.15M139.27M-119.00K5.29M1.61M17.81M31.96M
Capital Expenditure5.79M16.13M15.52M20.11M9.19M10.60M61.00K855.00K4.62M6.39M
Free Cash Flow-29.27M-43.92M-50.61M-72.83M-79.14M-16.81M-5.19M-18.35M-14.70M-6.59M
FCF to OCF124.63%158.07%144.24%138.15%113.13%270.78%74.95%104.89%146.59%103.03%

Earnings

Report DateDec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Jan 27, 2020May 7, 2020Aug 27, 2020Nov 11, 2020Jan 28, 2021Apr 20, 2021Jul 15, 2021Nov 11, 2021Mar 2, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022May 12, 2023Aug 31, 2023Nov 10, 2023Feb 16, 2024May 10, 2024Aug 23, 2024Nov 8, 2024Feb 14, 2025May 15, 2025Aug 22, 2025Nov 10, 2025Feb 16, 2026May 18, 2026Aug 24, 2026
EPS Estimate--------------------------------0.00-0.010.00----
EPS Actual-0.16-0.36-0.33-0.35-0.38-0.43-0.52-0.50-0.63-0.75-0.67-0.70-0.86-1.13-0.80-4.64-0.87-0.43-0.44-0.41-0.39-0.32-0.24-0.18-0.13-0.40-0.02-0.02-0.03-0.02-0.01-0.01-0.01-0.01-0.01-0.02-0.00-0.01-0.01
Surprise---------------------------------0.00%-----
Timing------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market----Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market----

Key Statistics & Ratios

Market Cap122.02M
Enterprise Value103.01M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.83
Price / Book3.07
EPS-0.03
Book Value0.147
Revenue (TTM)31.84M
Gross Profit (TTM)20.01M
EBITDA-5.91M
Profit Margin-24.51%
Operating Margin-22.48%
Return on Equity-18.64%
Return on Assets-9.98%
Shares Outstanding260.17M
Shares Float222.14M
Beta-0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%